Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023
Por um escritor misterioso
Descrição
VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. “It is an incredible honor to be recognized as one of the Fierce 15 biotech companies for 2023,” said Bernd Boidol, Ph.D., chief executive offi
Jacob Perrett on LinkedIn: VC funding update: Which Boston-area
Fierce Life Sciences Events on LinkedIn: The Future of Biotech
Mark Federici on LinkedIn: Crossbow Therapeutics Launches with $80
Chris Jenkins on LinkedIn: Gene Therapy Finds New Life in an Old Home
Introducing Fierce Biotech's 2023 Fierce 15
Jacob Perrett on LinkedIn: #analyticaldevelopment #sec
Proxygen LinkedIn
Fierce Biotech on LinkedIn: BrainStorm's ALS cell therapy
Georg Winter (@georg_e_winter) / X
Proxygen LinkedIn
Chris Jenkins on LinkedIn: #goteam #ibc #irb
Fierce Biotech on LinkedIn: The Future of Biotech
de
por adulto (o preço varia de acordo com o tamanho do grupo)
/i.s3.glbimg.com/v1/AUTH_08fbf48bc0524877943fe86e43087e7a/internal_photos/bs/2019/o/X/xLLXcDSTK1fS2rT8UftA/ekljqxbx0ae9xq9-1-.jpg)
